References
- Benedetti F , FrisaldiE . Creating placebo responders and nonresponders in the laboratory: boons and banes . Pain Manag.4 ( 3 ), 165 – 167 ( 2014 ).
- Evers AWM , CollocaL , BleaseCet al. Implications of placebo and nocebo effects for clinical practice: expert consensus . Psychother. Psychosom.12 ( 4 ), 204 – 210 ( 2018 ).
- Hashmi JA , BariaAT , BalikiMN , HuangL , SchnitzerTJ , ApkarianAV . Brain networks predicting placebo analgesia in a clinical trial for chronic back pain . Pain153 ( 12 ), 2393 – 2402 ( 2012 ).
- Schmidt-Wilcke T , IchescoE , HampsonJPet al. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients . Neuroimage Clin.6 , 252 – 261 ( 2014 ).
- Tétreault P , MansourA , Vachon-PresseauE , SchnitzerTJ , ApkarianAV , BalikiMN . Brain connectivity predicts placebo response across chronic pain clinical trials . PLoS Biol.14 ( 10 ), e1002570 ( 2016 ).
- Wager TD , AtlasLY . The neuroscience of placebo effects: connecting context, learning and health . Nat. Rev. Neurosci.16 ( 7 ), 403 – 418 ( 2015 ).
- Colloca L , PineDS , ErnstM , MillerFG , GrillonC . Vasopressin boosts placebo analgesic effects in women: a randomized trial . Biol. Psychiatry79 ( 10 ), 794 – 802 ( 2016 ).
- Kessner S , SprengerC , WrobelN , WiechK , BingelU . Effect of oxytocin on placebo analgesia: a randomized study . JAMA310 ( 16 ), 1733 – 1725 ( 2013 ).
- Corsi N , CollocaL . Placebo and nocebo effects: the advantage of measuring expectations and psychological factors . Front. Psychol.8 , 308 ( 2017 ).
- Darragh M , BoothRJ , ConsedineNS . Who responds to placebos? Considering the “placebo personality” via a transactional model . Psychol. Health Med.20 ( 3 ), 287 – 295 ( 2015 ).
- Benedetti F , FrisaldiE , CarlinoEet al. Teaching neurons to respond to placebos . J. Physiol.594 ( 19 ), 5647 – 5660 ( 2016 ).
- Shin CW , HahnS , ParkBJ , KimJM , ParkEO , JeonB . Predictors of the placebo response in clinical trials on Parkinson’s disease: a meta-analysis . Parkinsonism Relat. Disord.29 , 83 – 89 ( 2016 ).
- Weimer K , CollocaL , EnckP . Placebo effects in psychiatry: mediators and moderators . Lancet Psychiatry2 ( 3 ), 246 – 257 ( 2015 ).
- Rutherford BR , WallMM , BrownPJet al. Patient expectancy as a mediator of placebo effects in antidepressant clinical trials . Am. J. Psychiatry174 ( 2 ), 135 – 142 ( 2017 ).
- Zilcha-Mano S , RooseSP , BrownPJ , RutherfordBR . A machine learning approach to identifying placebo responders in late-life depression trials . Am. J. Geriatr. Psychiatry26 ( 6 ), 669 – 677 ( 2018 ).
- Elsenbruch S , EnckP . Placebo effects and their determinants in gastrointestinal disorders . Nat. Rev. Gastroenterol. Hepatol.12 ( 8 ), 472 – 485 ( 2015 ).
- Hall KT , LoscalzoJ , KaptchukTJ . Genetics and the placebo effect: the placebome . Trends Mol. Med.21 ( 5 ), 285 – 294 ( 2015 ).
- Younger J , GandhiV , HubbardE , MackeyS . Development of the stanford expectations of treatment scale (SETS): a tool for measuring patient outcome expectancy in clinical trials . Clin. Trials9 ( 6 ), 767 – 776 ( 2012 ).
- Mestre TA , ShahP , MarrasC , TomlinsonG , LangAE . Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses . Neurology82 ( 16 ), 1402 – 1409 ( 2014 ).
- Grahl A , OnatS , BüchelC . The periaqueductal gray and Bayesian integration in placebo analgesia . Elife7 , e32930 ( 2018 ).